New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
06:10 EDTEVARLombard Medical announces Aorfix received approval in Japan
Lombard Medical announced that its lead product, Aorfix, an endovascular stent graft to treat AAA, has received approval from the Japanese Ministry of Health, Labour and Welfare. Commercial sales will follow reimbursement approval, which the Company anticipates receiving in September. Aorfix will be exclusively distributed by Medico's Hirata.
News For EVAR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
08:45 EDTEVARLombard Medical's Aorfix stent graft shows positive results in two-year trial
Lombard Medical presented efficacy and safety data from the two-year follow up of the U.S. Pythagoras pre-marketing approval trial of Aorfix, the endovascular stent graft with global approvals for the treatment of patients with aortic neck angulations up to 90 degrees. The data showed 100% freedom from aneurysm rupture, 98% freedom from Type I & III endoleaks and 99% freedom from device migration in patients with a 60 to 90 degree aortic neck angulation, a group typically considered difficult-to-treat and associated with poor treatment outcomes.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use